Nexsen Limited (ASX:NXN)

Australia flag Australia · Delayed Price · Currency is AUD
0.2400
+0.0050 (2.13%)
Last updated: Jul 31, 2026, 11:51 AM AEST
Market Cap48.05M
Revenue (ttm)931.61K +47.4%
Net Income-8.46M
EPS-0.04
Shares Out 200.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume160,684
Open0.2400
Previous Close0.2350
Day's Range0.2300 - 0.2400
52-Week Range0.1300 - 0.3450
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateSep 4, 2026

About Nexsen

Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NXN
Full Company Profile

Financial Performance

Financial Statements